What is the market price of palbociclib/palbociclib in China?

Palbociclib (Palbociclib), also known as palbociclib, is an innovative oral targeted therapy. This drug is mainly used to treat hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative locally advanced or metastatic breast cancer, especially for postmenopausal female patients.

The main mechanism of action of palbociclib is to inhibit the activity of cyclin-dependent kinases (CDKs) 4 and 6. These two kinases are key regulators of the cell cycle and can trigger cell cycle progression. By inhibiting the activity of these two kinases, palbociclib can prevent cancer cells from entering the S phase from the G1 phase, thereby inhibiting the proliferation, differentiation and growth of cancer cells.

Palbociclib has been proven in clinical trials to significantly extend patients' survival and improve their quality of life. In addition, it can be used in combination with aromatase inhibitors as initial endocrine therapy for postmenopausal female patients to enhance the effect of chemotherapy and reduce cancer cell resistance to drugs.

However, palbociclib may also cause some side effects, such as neutropenia, anemia, gastrointestinal discomfort, etc. Therefore, when using palbociclib, the patient's physical condition needs to be closely monitored and adjustments and treatments should be made according to the doctor's guidance.

Overall, palbociclib is an important anticancer drug that brings new treatment options and hope to many breast cancer patients. When using it, patients should follow medical advice, pay attention to their physical condition, and report any discomfort to the doctor in a timely manner.

Pabociclib is now on the market in the country and has been included in the medical insurance reimbursement system. Based on the common domestic dosage of 125mg*21 tablets, patients will have to pay approximately 4,200 yuan after reimbursement by medical insurance. At the same time, we can also look at the palbociclib market overseas, where there are two types of drugs: original research and generics. The price of overseas original drugs is higher than that after reimbursement in China, so if patients need it, it is more cost-effective to buy it directly from China. As for overseas generic drugs, they are mainly made in Bangladesh and Laos. The prices of products from different manufacturers in Bangladesh fluctuate between 780 and 2,800 yuan.